Skip to content

Clinical trials

Phase 1 Ovarian Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Country / region: Australia Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20151
20163
20174
20184
20194
20204
20223
20235
202412
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting11
Recruiting11
Terminated7
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Arcus Biosciences, Inc.3
Eli Lilly and Company3
MacroGenics3
Amgen2
BeiGene2
Monopar Therapeutics2
Pfizer2
Actym Therapeutics, Inc.1
Alterome Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms47
Carcinoma, Non-Small-Cell Lung22
Triple Negative Breast Neoplasms21
Breast Neoplasms20
Endometrial Neoplasms17
Pancreatic Neoplasms17
Stomach Neoplasms17
Colorectal Neoplasms16
Uterine Cervical Neoplasms15
Urinary Bladder Neoplasms13

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.